CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report (Q38978741)

8 September 2017

CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report (English)

1 reference

8 September 2017

1 reference

12

1 reference

8 September 2017

Javier Martinez-Picado

16

1 reference

8 September 2017

Bonaventura Clotet Sala

13

object named as

Bonaventura Clotet

1 reference

8 September 2017

Rafael F Duarte

1

1 reference

8 September 2017

María Salgado

2

1 reference

8 September 2017

Isabel Sánchez-Ortega

3

1 reference

8 September 2017

Montserrat Arnan

4

1 reference

8 September 2017

Carmen Canals

5

1 reference

8 September 2017

Eva Domingo-Domenech

6

1 reference

8 September 2017

Alberto Fernández-de-Sevilla

7

1 reference

8 September 2017

Eva González-Barca

8

1 reference

8 September 2017

Sara Morón-López

9

1 reference

8 September 2017

Nuria Nogues

10

1 reference

8 September 2017

Beatriz Patiño

11

1 reference

8 September 2017

Lawrence D Petz

14

1 reference

8 September 2017

Sergio Querol

15

1 reference

8 September 2017

19 May 2015

1 reference

8 September 2017

1 reference

8 September 2017

2

1 reference

8 September 2017

e236-42

1 reference

8 September 2017

6

1 reference

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Can HIV be cured with stem cell therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Transplantation in HIV-infected subjects: is cure possible?

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Global distribution of the CCR5 gene 32-basepair deletion.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Umbilical cord blood transplantation: the first 25 years and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Hematopoietic cell transplantation with cord blood for cure of HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Bioinformatics prediction of HIV coreceptor usage

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Web resources for HIV type 1 genotypic-resistance test interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3018%2815%2900083-1

7 January 2021

10.1016/S2352-3018(15)00083-1

Identifiers

DOI

1 reference

8 September 2017

1 reference